Source

Author:

Michael Hiltzik

Preview:

Despite promises that the big GOP corporate tax cut would lead to more corporate investment, Pfizer is steering $10 billion to its shareholders and ending its investment in Alzheimer's research.

---

Hello I am a friendly bot